 SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 28, 2022 GLOBE NEWSWIRE -- Landec Corporation Nasdaq: LNDC Landec or the Company, a diversified health and wellness company focused on its growing Lifecore Biomedical Lifecore business a fully integrated contract development and manufacturing organization CDMO that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials today announced a change to its previously announced fiscal 2023 first quarter earnings conference call date in recognition of Yom Kippur. 